Literature DB >> 10627425

Macrovascular disease and systemic sclerosis.

M Ho1, D Veale, C Eastmond, G Nuki, J Belch.   

Abstract

OBJECTIVE: To determine if macrovascular disease is more prevalent in systemic sclerosis (SSc) compared with unaffected subjects.
METHODS: 54 patients with SSc (both limited and diffuse disease) and 43 unaffected control subjects of similar age and sex were recruited. All subjects underwent a basic screen for conventional atherosclerotic disease risk factors. All had non-invasive vascular assessments-that is, carotid duplex scanning and measurement of ankle brachial blood pressure index-to identify the presence of asymptomatic peripheral vascular disease.
RESULTS: 33 of 52 (64%) patients had carotid artery disease compared with only 15 of 42 (35%) controls (p=0.007). Eleven (21%) of these patients had moderate disease compared with only two (5%) controls (NS). Nine of 53 (17%) SSc patients had evidence of peripheral arterial disease compared with no controls. This result was also statistically significant (p=0.003). There were no significant differences in the basic risk factor profile, which included cigarette smoking, systolic and diastolic blood pressure, cholesterol, trigyceride and glucose concentrations.
CONCLUSION: Macrovascular disease is more common in SSc. Screening of these patients may allow identification of "at risk" patients at an early stage and allow the study of treatments to attenuate the high rate of cardiovascular mortality in these patients.

Entities:  

Mesh:

Year:  2000        PMID: 10627425      PMCID: PMC1752979          DOI: 10.1136/ard.59.1.39

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Pathological changes in progressive systemic sclerosis.

Authors:  T T ANTONOVYCH; L C STEINGASZNER
Journal:  Georgetown Med Bull       Date:  1962-08

Review 2.  Treatment of generalized systemic sclerosis.

Authors:  M A Torres; D E Furst
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

3.  Vascular damage and factor-VIII-related antigen in the rheumatic diseases.

Authors:  J J Belch; A A Zoma; I M Richards; K McLaughlin; C D Forbes; R D Sturrock
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.

Authors:  J Masuda; R Ross
Journal:  Arteriosclerosis       Date:  1990 Mar-Apr

5.  Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosis.

Authors:  J G Larkin; J J Belch; P Flanigan; C D Forbes; B M Frier
Journal:  Diabet Med       Date:  1988-01       Impact factor: 4.359

6.  The detection and progression of asymptomatic peripheral arterial disease.

Authors:  S Laing; R M Greenhalgh
Journal:  Br J Surg       Date:  1983-10       Impact factor: 6.939

7.  Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation.

Authors:  J Masuda; R Ross
Journal:  Arteriosclerosis       Date:  1990 Mar-Apr

8.  The natural history of carotid arterial disease in asymptomatic patients with cervical bruits.

Authors:  G O Roederer; Y E Langlois; K A Jager; J F Primozich; K W Beach; D J Phillips; D E Strandness
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

9.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

Authors:  W A D'Angelo; J F Fries; A T Masi; L E Shulman
Journal:  Am J Med       Date:  1969-03       Impact factor: 4.965

10.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

Authors:  F G Fowkes; E Housley; E H Cawood; C C Macintyre; C V Ruckley; R J Prescott
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

View more
  42 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

2.  Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state.

Authors:  P J Kotyla; J Gozdzik; M Lewicki; A T Kotulska; E J Kucharz
Journal:  Rheumatol Int       Date:  2005-11-12       Impact factor: 2.631

3.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

4.  The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function.

Authors:  Alma Cypiene; Aleksandras Laucevicius; Algirdas Venalis; Jolanta Dadoniene; Ligita Ryliskyte; Zaneta Petrulioniene; Milda Kovaite; Jonas Gintautas
Journal:  Clin Rheumatol       Date:  2008-07-25       Impact factor: 2.980

Review 5.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 6.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

7.  Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Daniele Prati; Giovanni Barausse; Ilaria Tinazzi; Viviana Ravagnani; Silvia Confente; Domenico Biasi
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

Review 8.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

9.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

10.  Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.

Authors:  Emma C Derrett-Smith; Audrey Dooley; Korsa Khan; Xu Shi-wen; David Abraham; Christopher P Denton
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.